Pulmonary Disease Doctors in Santa Cruz, CA Accepting Medicare

9 Pulmonary Disease doctors found. Showing 1 - 9

Mr. Aaron B Morse, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1665 Dominican Way, Suite 222a, Santa Cruz, CA 95065 Phone: 831-465-0586    Fax: 831-476-5292

Dr. Randall James Rea, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 700 Frederick St Ste 203, Santa Cruz, CA 95062 Phone: 831-425-1906    Fax: 831-469-8764

Don Hodges, Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2025 Soquel Ave, Santa Cruz, CA 95062 Phone: 831-423-4111

Dr. James Anthony Louisell, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1595 Soquel Dr Ste 230, Santa Cruz, CA 95065 Phone: 831-226-3225    Fax: 831-423-7579

Dr. Andrea Ling, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1595 Soquel Dr Ste 230, Santa Cruz, CA 95065 Phone: 831-226-3225    Fax: 831-423-7579

Mr. Anthony Russo, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 219 20th Ave, Santa Cruz, CA 95062 Phone: 650-483-7703

Dr. Maly Nathalie Oron, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2025 Soquel Ave, Santa Cruz, CA 95062 Phone: 831-423-4111

Lily Zeng, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1595 Soquel Dr Ste 230, Santa Cruz, CA 95065 Phone: 831-226-3225    Fax: 831-423-7579

Dr. David Leo Kipps, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 700 Frederick St Ste 203, Santa Cruz, CA 95062 Phone: 831-425-1906    Fax: 831-469-8764

News Archive

Delcath Systems begins operations facility in Queensbury, New York

Delcath Systems, Inc. (Nasdaq: DCTH), a Manhattan headquartered medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that it has signed a three-year lease with the option to buy on a 10,000 square foot facility in Queensbury, New York in which it plans to locate manufacturing of its Percutaneous Hepatic Perfusion (PHP(TM)) System.

Mutant HSP70i protein may offer potent treatment opportunities for vitiligo

Loyola University Chicago Stritch School of Medicine researchers have developed a genetically modified protein that dramatically reverses the skin disorder vitiligo in mice, and has similar effects on immune responses in human skin tissue samples.

Allergan notes public filings made by Pershing Square and Valeant Pharmaceuticals

Allergan, Inc. ("Allergan" or the "Company") today became aware of public filings made by Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") regarding Valeant's purported intention to propose a merger in which the Company's stockholders would receive a combination of Valeant common shares and cash in exchange for the outstanding shares of the Company's common stock.

Microbes go dormant in the presence of SSV9 virus

The microbes could surrender to the harmless virus, but instead freeze in place, dormant, waiting for their potential predator to go away, according to a recent study in mBio.

‘Bioactive' coils disappoint for cerebral aneurysms

The angiographic outcomes of patients in the Cerecyte Coil Trial add to evidence that "bioactive" coils are no better than bare platinum coils in patients with cerebral aneurysms.

Read more Medical News

› Verified 7 days ago